Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Oncology|July 14, 2025
Risk stratification for recurrence after nephrectomy in high-risk renal cell carcinoma patientsTaisuke Tobe, Jun Teishima, Hideto Ueki, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|September 2, 2022
N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZYusuke Shiraishi, Tomohiko Maehama, Miki Nishio, et al.Respiration; International Review of Thoracic Diseases|January 23, 2023
Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow LimitationTomoki Maetani, Naoya Tanabe, Yusuke Shiraishi, et al.The European Respiratory Journal|February 26, 2026
Persistent homology analysis of longitudinal CT fibrotic features in COPDYusuke Shiraishi, Naoya Tanabe, Shizuo Kaji, et al.Hinyokika Kiyo. Acta Urologica Japonica|March 6, 2014
[Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification]Noriaki Utsunomiya, Yuka Kono, Keiyu Matsumoto, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[THE IMPACT OF LOWER URINARY TRACT SYMPTOMS ON GENERIC HEALTH-RELATED QUALITY OF LIFE IN MALE PATIENTS WITHOUT CO-MORBIDITY]Takuya Okada, Yuka Kono, Keiyu Matsumoto, et al.International Journal of Clinical Oncology|May 27, 2026
Comparison of effectiveness and safety of pembrolizumab plus lenvatinib versus nivolumab plus cabozantinib for metastatic renal cell carcinoma: a real-world studyTaisuke Tobe, Jun Teishima, Yoshie Mita, et al.Oncology Letters|October 9, 2023
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 6, 2024
Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.Scientific Reports|April 5, 2022
Associations of pulmonary and extrapulmonary computed tomographic manifestations with impaired physical activity in symptomatic patients with chronic obstructive pulmonary diseaseYoko Hamakawa, Naoya Tanabe, Hiroshi Shima, et al.Pageof 11